Innovation trends from R&D to market access

Published on December 12, 2024

2024 has been an incredibly busy year for Norstella as its constituent organizations – Citeline, Evaluate, MMIT, Panalgo, and the Dedham Group – have continued to support the biopharma ecosystem in bringing new therapies to patients. Throughout the course of the year, we have also shared our latest views on the issues that are most […]

Continue reading on website
Other news

InnovAge Celebrates 35 Years of Transforming Senior Care

December 12, 2024
Has helped over 24,400 Seniors Age Safely at Home Since Its Inception DENVER, Dec. 12, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), the nation’s largest provider of the Program of All-inclusive Care for the Elderly (PACE) based on census, proudly celebrates 35 years

BrightPath Bio and Cellistic® Announce Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT Celll

December 13, 2024
Tokyo, Japan and Mont-Saint-Guibert, Belgium, – December 13th, 2024 - BrightPath Bio (Tokyo Stock Exchange Growth 4594, “BrightPath”), a pioneer in iPS cell-derived Natural Killer T (“NKT”) cell therapy, and Cellistic, a leader in advanced iPS cell therapy manufacturing, today announced a process development and manufacturing agreement to advance BrightPath’s novel allogeneic CAR-T cell therapy pl